| Name | Title | Contact Details |
|---|
Healthcare Consulting Group is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Custom Granular is a Genoa City, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clinical Resources Group is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sun Healthcare Group, Inc. and its subsidiaries provide health care services primarily for senior population in the United States. It operates skilled nursing centers, which offer daily nursing, therapeutic rehabilitation, social, housekeeping, nutrition, and administrative services for individuals requiring certain assistance for activities in daily living. The company also operates assisted living centers that provide minimal nursing assistance, housekeeping, nutrition, laundry, and administrative services for individuals requiring minimal assistance for activities in daily living; and independent living centers, which offer security, housekeeping, nutrition, and limited laundry services for individuals requiring no assistance for activities in daily living. In addition, it operates mental health centers, which provide inpatient and outpatient behavioral health services for adults and children, as well as offers hospice services, including palliative care, social services, pain management, and spiritual counseling in 11 states. Further, the company offers rehabilitation therapy services, including speech pathology, physical therapy, and occupational therapy. Additionally, it offers temporary medical staffing comprising licensed therapists in the areas of physical, occupational, and speech therapy; nurses; pharmacists, pharmacist technicians, and medical imaging technicians physicians; and related medical personnel for hospitals and other providers, skilled nursing centers, schools, and prisons in 40 states. The company was founded in 1989 and is based in Irvine, California. As of December 3, 2012, Sun Healthcare Group, Inc. operates as a subsidiary of Genesis HealthCare LLC.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.